Micro- and Nano-Carrier Mediated Intra-Articular Drug Delivery Systems for the Treatment of Osteoarthritis

Citations Over TimeTop 10% of 2011 papers

Abstract

The objective of this paper is to provide readers with current developments of intra-articular drug delivery systems. In recent years, although the search for a clinically successful ideal carrier is ongoing, sustained-release systems, such as polymeric micro- and nanoparticles, liposomes, and hydrogels, are being extensively studied for intra-articular drug delivery purposes. The advantages associated with long-acting preparations include a longer effect of the drug in the action site and a reduced risk of infection due to numerous injections consequently. This paper discusses the recent developments in the field of intra-articular sustained-release delivery systems for the treatment of osteoarthritis.

Related Papers

• Liposomes: a drug carrier system for topical treatment in dermatology.(1994)
• → Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.(1988)21 cited
• → Vesicular Phospholipid Gels(2003)7 cited
• → Manipulation of Kupffer cells by liposome encapsulated clodronate and propamidine—synergistic and antagonistic effects of liposomal phospholipids and drugs(1998)5 cited
• Application of liposomes as carriers of anti-tumor drugs(2009)